Gabelli Funds’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-181,442
Closed -$4.19M 1457
2020
Q4
$4.19M Buy
+181,442
New +$4.19M 0.03% 525